Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,668 | 149 | 96.9% |
| Education | $243.98 | 3 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,754 | 35 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,250 | 14 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $1,116 | 18 | $0 (2019) |
| Lilly USA, LLC | $817.36 | 19 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $464.99 | 4 | $0 (2020) |
| Celgene Corporation | $404.03 | 10 | $0 (2019) |
| Genentech USA, Inc. | $338.93 | 4 | $0 (2019) |
| GENZYME CORPORATION | $323.57 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $319.23 | 9 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $214.30 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $629.27 | 20 | ABBVIE INC. ($246.07) |
| 2023 | $33.20 | 2 | ABBVIE INC. ($19.50) |
| 2022 | $64.99 | 1 | Incyte Corporation ($64.99) |
| 2021 | $28.01 | 2 | Galderma Laboratories, L.P. ($28.01) |
| 2020 | $601.49 | 14 | Janssen Scientific Affairs, LLC ($247.37) |
| 2019 | $2,983 | 52 | Regeneron Healthcare Solutions, Inc. ($636.74) |
| 2018 | $2,123 | 40 | Novartis Pharmaceuticals Corporation ($704.67) |
| 2017 | $1,449 | 21 | AbbVie, Inc. ($478.39) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.14 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.30 | General |
| Category: Immunology | ||||||
| 09/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $105.69 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Immunology | ||||||
| 08/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| Category: Immunology | ||||||
| 08/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: DERMATOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Immunology | ||||||
| 07/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.42 | General |
| Category: Immunology | ||||||
| 06/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Immunology | ||||||
| 06/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.67 | General |
| Category: Immunology | ||||||
| 05/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Immunology | ||||||
| 04/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $70.94 | General |
| Category: IMMUNOLOGY | ||||||
| 04/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Immunology | ||||||
| 04/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Immunology | ||||||
| 09/15/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: DERMATOLOGY | ||||||
| 04/13/2022 | Incyte Corporation | — | Education | Cash or cash equivalent | $64.99 | General |
| 03/16/2021 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: ACNE | ||||||
| 02/10/2021 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.03 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,431 | 2,608 | $347,035 | $125,475 |
| 2022 | 13 | 1,104 | 2,203 | $259,353 | $94,606 |
| 2021 | 15 | 808 | 1,268 | $189,346 | $73,195 |
| 2020 | 4 | 144 | 153 | $29,535 | $11,378 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 386 | 554 | $121,880 | $45,957 | 37.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 249 | 354 | $44,250 | $14,238 | 32.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 85 | 120 | $18,480 | $9,332 | 50.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 102 | 115 | $17,250 | $7,939 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 127 | $18,415 | $7,839 | 42.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 103 | 103 | $22,145 | $7,730 | 34.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 18 | 20 | $14,440 | $6,170 | 42.7% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 13 | 14 | $14,098 | $5,099 | 36.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 185 | 895 | $30,430 | $4,302 | 14.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 25 | 28 | $5,992 | $3,301 | 55.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $8,375 | $2,815 | 33.6% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 13 | 29 | $5,945 | $2,443 | 41.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 20 | 21 | $3,885 | $2,025 | 52.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 19 | $7,239 | $1,885 | 26.0% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 25 | 41 | $3,854 | $1,656 | 43.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 28 | 37 | $2,775 | $1,429 | 51.5% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $5,232 | $1,238 | 23.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 28 | 94 | $2,350 | $76.19 | 3.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 446 | $97,740 | $40,607 | 41.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 210 | 277 | $34,625 | $11,826 | 34.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 154 | 154 | $33,110 | $10,467 | 31.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 62 | 80 | $12,320 | $6,332 | 51.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 17 | 17 | $12,274 | $5,731 | 46.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 79 | 84 | $12,600 | $5,612 | 44.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 157 | 961 | $32,674 | $4,834 | 14.8% |
About Sarah Hocker
Sarah Hocker is a Dermatology healthcare provider based in Everett, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1689068736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Hocker has received a total of $7,912 in payments from pharmaceutical and medical device companies, with $629.27 received in 2024. These payments were reported across 152 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($7,668).
As a Medicare-enrolled provider, Hocker has provided services to 3,487 Medicare beneficiaries, totaling 6,232 services with total Medicare billing of $304,654. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Everett, PA
- Active Since 03/26/2015
- Last Updated 12/05/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1689068736
Products in Payments
- COSENTYX (Biological) $1,116
- Humira (Biological) $968.91
- DUPIXENT (Biological) $747.93
- DUPIXENT DUPILUMAB INJECTION (Biological) $613.03
- TALTZ (Drug) $489.73
- Otezla (Drug) $435.42
- TREMFYA (Drug) $414.03
- Erivedge (Biological) $338.93
- Skyrizi (Biological) $273.79
- SKYRIZI (Biological) $211.47
- SILIQ (Drug) $201.57
- STELARA (Biological) $201.22
- DUPIXENT (Drug) $189.56
- Tremfya (Drug) $131.76
- VALCHLOR (Drug) $121.17
- HUMIRA (Biological) $117.39
- Enbrel (Biological) $110.00
- Sotyktu (Drug) $75.90
- RINVOQ (Biological) $70.94
- EUCRISA (Drug) $56.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Everett
Dr. Susan Oldenkamp, M.d, M.D
Dermatology — Payments: $3,382
Dr. Mark Valentine, M.d, M.D
Dermatology — Payments: $3,005
Lucy Chao, Md, MD
Dermatology — Payments: $1,872
Hana Stelle, M.d, M.D
Dermatology — Payments: $1,634
Dr. Teerawit Supakorndej, Md, MD
Dermatology — Payments: $688.13
Dr. Zarry Tavakkol, M.d, M.D
Dermatology — Payments: $165.03